These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 22250951)

  • 1. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice.
    Siddiq F; Chaudhry SA; Khatri R; Rodriguez GJ; Tummala R; Suri MF; Qureshi AI
    Neurosurgery; 2012 Jul; 71(1):68-73. PubMed ID: 22382209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience.
    Krajíčková D; Krajina A; Lojík M; Mulačová M; Vališ M
    Vasa; 2013 Jul; 42(4):264-74. PubMed ID: 23823858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
    Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
    Marks MP
    Stroke; 2012 Feb; 43(2):580-4. PubMed ID: 22246690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.
    Fiorella D; Levy EI; Turk AS; Albuquerque FC; Niemann DB; Aagaard-Kienitz B; Hanel RA; Woo H; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG
    Stroke; 2007 Mar; 38(3):881-7. PubMed ID: 17290030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
    Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ;
    Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.
    Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology.
    Yu SC; Cheng HK; Cheng PW; Lui WM; Leung KM; Tan CB; Pang KY; Wong GK; Cheung YL; Lee R; Wong YC; Wong CK; Kwok JC;
    Hong Kong Med J; 2013 Feb; 19(1):69-73. PubMed ID: 23378358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.
    Derdeyn CP; Fiorella D; Lynn MJ; Rumboldt Z; Cloft HJ; Gibson D; Turan TN; Lane BF; Janis LS; Chimowitz MI;
    Neurosurgery; 2013 May; 72(5):777-95; discussion 795. PubMed ID: 23328689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
    Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
    J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death.
    Suri MF; Tariq N; Siddiq F; Vazquez G; Taylor RA; Tummala RP; Wojak JC; Chaloupka JC; Qureshi AI
    J Endovasc Ther; 2010 Jun; 17(3):314-9. PubMed ID: 20557168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial stent placement for symptomatic intracranial stenosis as part of a clinical trial versus outside a clinical trial.
    Siddiq F; Adil MM; Norby K; Qureshi AI
    Stroke; 2013 Dec; 44(12):3571-2. PubMed ID: 24135930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
    Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
    Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.
    Fiorella D; Turan TN; Derdeyn CP; Chimowitz MI
    J Neurointerv Surg; 2009 Jul; 1(1):35-9. PubMed ID: 21994103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.